kyg.
Lobbying client

RAREi - The Canadian Forum for Rare Disease Innovators

126 total contacts75 distinct DPOHsNov 2, 2018 – Apr 22, 2026see all signals (grants + contracts + lobbying) →

Who they lobby

  1. 1.Tom Kmiec6
    Member of Parliament · House of Commons
  2. 2.Francis Drouin5
    Member of Parliament · House of Commons
  3. 3.Sandenga Yeba4
    Senior Policy Advisor · Health Canada (HC)
  4. 4.Daniel MacDonald3
    Director General · Health Canada (HC)
  5. 5.Brent Lawlor3
    Director · Health Canada (HC)
  6. 6.Francesco Sorbara3
    Member of Parliament · House of Commons
  7. 7.Francesco Sorbara3
    Member of Parliment · House of Commons
  8. 8.Earl Dreeshen2
    Member of Parliament · House of Commons
  9. 9.Andrew Swidzinski2
    Advisor · House of Commons
  10. 10.Douglas Clark2
    Executive Director · Patented Medicine Prices Review Board (PMPRB)
  11. 11.Rodrigo Arancibia2
    Director · Innovation, Science and Economic Development Canada (ISED)
  12. 12.Alupa A. Clarke2
    Member of Parliament · House of Commons
  13. 13.Adam Vaughan2
    Member of Parliament · House of Commons
  14. 14.Bernard Généreux2
    Member of Parliament · House of Commons
  15. 15.Tanya Potashnik2
    Director of Policy and Economic Analysis · Patented Medicine Prices Review Board (PMPRB)
  16. 16.Majid Jowhari2
    Member of Parliament · House of Commons
  17. 17.Jean-Francois Harvey2
    Regional Advisor - Québec · Health Canada (HC)
  18. 18.Guillaume Couillard2
    Executive Director · Patented Medicine Prices Review Board (PMPRB)
  19. 19.Gabriel Ste-Marie2
    Member of Parliament · House of Commons
  20. 20.Adam Van Koeverden2
    Member of Parliament · House of Commons
  21. 21.Melissa Lantsman2
    Member of Parliament · House of Commons
  22. 22.Richard Martel1
    Member of Parliament · House of Commons
  23. 23.Michelle Rempel Garner1
    Member of Parliament · House of Commons
  24. 24.Omar Alghabra1
    Member of Parliament · House of Commons
  25. 25.Doug Eyolfson1
    Member of Parliament & Member of HESA · House of Commons

Institutions targeted

  • House of Commons83
  • Health Canada (HC)24
  • Innovation, Science and Economic Development Canada (ISED)7
  • Patented Medicine Prices Review Board (PMPRB)7
  • Senate of Canada5

Recent contacts